These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8237148)
1. [Prognostic factors in breast cancer--classification in non-university hospitals]. Willner J; Kiricuta IC; Kölbl O; Bohndorf W Zentralbl Chir; 1993; 118(9):525-31. PubMed ID: 8237148 [TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
3. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor. Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485 [TBL] [Abstract][Full Text] [Related]
4. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related]
5. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors in medullary breast cancer]. Mitze M; Goepel E Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051 [TBL] [Abstract][Full Text] [Related]
7. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
8. Primary tumour characteristics and axillary lymph node status in breast cancer. Yiangou C; Shousha S; Sinnett HD Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048 [TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible? Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [TBL] [Abstract][Full Text] [Related]
11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
12. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M Breast J; 2008; 14(6):551-5. PubMed ID: 19000054 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459 [TBL] [Abstract][Full Text] [Related]
14. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla? Martelli G; Miceli R; De Palo G; Coradini D; Salvadori B; Zucali R; Galante E; Marubini E Cancer; 2003 Mar; 97(5):1156-63. PubMed ID: 12599220 [TBL] [Abstract][Full Text] [Related]
15. Negative margin status improves local control in conservatively managed breast cancer patients. Obedian E; Haffty BG Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736 [TBL] [Abstract][Full Text] [Related]
16. The lymph node ratio as prognostic factor in node-positive breast cancer. Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006 [TBL] [Abstract][Full Text] [Related]
17. [Management of the axilla in breast cancer: evidences and unresolved issues]. Fodor J; Polgár C; Péley G; Németh G Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099 [TBL] [Abstract][Full Text] [Related]
18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
19. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer. Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of prognostic factors in breast cancer]. Durand M Bull Cancer; 1984; 71(4):331-5. PubMed ID: 6498347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]